diabetes mellitus | Research | Treatment | 10 pages | source: The New England Journal of Medicine | Added Aug 16, 2021
Is tirzepatide as effective as semaglutide for the treatment of type 2 diabetes?
This study looked at tirzepatide, a new treatment for type 2 diabetes, compared to semaglutide (Ozempic). It found that, depending on the dose, tirzepatide was similarly or more effective at controlling blood glucose than semaglutide.
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes, Obesity and Metabolism | Added Aug 13, 2021
Is liraglutide an effective add-on treatment for poorly controlled type 2 diabetes?
This study evaluated whether liraglutide (Victoza) improves diabetic control in patients with difficult to control type 2 diabetes (T2D) and if there were certain factors that influence the effects of liraglutide. It found that patients responded equally well to liraglutide regardless of body mass index (BMI; a measurement of weight in relation to height), diabetes duration, and other factors.
diabetes mellitus | Research | 10 pages | source: International urology and nephrology | Added Aug 11, 2021
Can piperazine ferulate help to prevent diabetic kidney disease?
This study looked at the use of piperazine ferulate (PF) in diabetic patients. It found that adding PF to angiotensin receptor blocker (ARB) treatment helped to protect kidney function in patients with diabetes.
diabetes mellitus | Research | Treatment | 10 pages | source: Lancet (London, England) | Added Aug 09, 2021
Is tirzepatide a safe and effective treatment for type 2 diabetes?
This study looked at the safety and effectiveness of tirzepatide (LY-3298176) in patients with type 2 diabetes (T2D) inadequately controlled by diet and exercise alone. It found that compared to placebo, tirzepatide improved diabetes control and weight in these patients.
diabetes mellitus | Research | Treatment | 8 pages | source: Diabetes, Obesity and Metabolism | Added Aug 07, 2021
Is insulin detemir or insulin glargine more effective in type 2 diabetes?
This study evaluated the safety and effectiveness of once-daily insulin detemir and insulin glargine when added to metformin therapy in type 2 diabetes patients.
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes, Obesity and Metabolism | Added Aug 05, 2021
Insulin degludec for the treatment of type 2 diabetes
This study examined whether insulin degludec is safe and effective when combined with metformin and liraglutide. The authors concluded that insulin degludec is safe and effective as an add-on therapy.
diabetes mellitus | Research | Treatment | 9 pages | source: Diabetes, Obesity and Metabolism | Added Aug 03, 2021
Three's company: Albiglutide is an effective third add-on to metformin therapy
The current study examined the safety and efficacy of albiglutide (Tanzeum) when used in combination with metformin (Glucophage) and glimepiride (Amaryl) in type 2 diabetes.
diabetes mellitus | Research | Treatment | 8 pages | source: Diabetes, Obesity and Metabolism | Added Aug 01, 2021
Evaluating safety and efficacy of a new drug for patients with type 2 diabetes mellitus
This study assessed the efficacy and safety of adding gemigliptin versus sitagliptin to metformin treatment in patients with type 2 diabetes mellitus (T2DM).
diabetes mellitus | Research | Lifestyle | 5 pages | source: Gastroenterology | Added Jul 30, 2021
Does gender affect your chances of getting gastroparesis in type 2 diabetes?
The aim of this study was to investigate the association of gender and various factors such as disease duration, age, blood sugar level and weight with gastroparesis in type 2 diabetes patients.
diabetes mellitus | Research | Treatment | 7 pages | source: PLOS ONE | Added Jul 28, 2021
Lobeglitazone: A novel antidiabetic drug
This study analyzed the glucose-lowering effects of lobeglitazone, a novel antidiabetic drug.
